Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2022-03-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
NCT01398644
Iron Depletion and Replacement in Blood Donors
NCT01752413
Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency
NCT03079518
The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
NCT00230165
Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
NCT00202436
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Simulated plasma donation, same procedure as for plasmapheresis but without drawing blood.
Plasmapheresis
Plasma donation at different frequencies
Low-frequency
Plasma donation 1x/month for 3 months
Plasmapheresis
Plasma donation at different frequencies
High-frequency
Plasma donation 3x/month for 3 months
Plasmapheresis
Plasma donation at different frequencies
US scheme
Plasma donation 2x/week for 3 months
Plasmapheresis
Plasma donation at different frequencies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Plasmapheresis
Plasma donation at different frequencies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 18-50 years
* BMI between 20-28 kg/m2
* aptitude to perform maximal physical efforts assessed by the physical activity readiness questionnaire (PAR-Q)
Exclusion Criteria
* In case the subjects comply, their plasma donations will be handled as usually.
* The criteria will be assessed before each plasma donation by a questionnaire as usually done in the Center of the Rode Kruis.
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université Catholique de Louvain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCLouvain
Louvain-la-Neuve, Brabant Wallon, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RK2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.